PT - JOURNAL ARTICLE AU - Christopher G Jacob AU - Nguyen Thuy-Nhien AU - Mayfong Mayxay AU - Richard J Maude AU - Huynh Hong Quang AU - Bouasy Hongvanthong AU - Viengxay Vanisaveth AU - Thang Ngo Duc AU - Huy Rekol AU - Rob W van der Pluijm AU - Lorenz Von Seidlein AU - Rick M Fairhurst AU - Francois H Nosten AU - Md Amir Hossain AU - Naomi Park AU - Scott Goodwin AU - Pascal Ringwald AU - Keobouphaphone Chindavongsa AU - Paul N Newton AU - Elizabeth A Ashley AU - Sonexay Phalivong AU - Rapeephan R Maude AU - Rithea Leang AU - Cheah Huch AU - Le Thanh Dong AU - Kim-Tuyen Nguyen AU - Tran Minh Nhat AU - Tran Tinh Hien AU - Hoa Nguyen AU - Nicole Zdrojewski AU - Sara E Canavati AU - Abdullah Abu Sayeed AU - Didar Uddin AU - Caroline Buckee AU - Caterina I Fanello AU - Marie Onyamboko AU - Thomas Peto AU - Rupam Tripura AU - Chanaki Amaratunga AU - Aung Myint Thu AU - Gilles Delmas AU - Jordi Landier AU - Daniel M Parker AU - Nguyen Hoang Chau AU - Dysoley Lek AU - Seila Suon AU - James J Callery AU - Podjanee Jittamala AU - Borimas Hanboonkunupakarn AU - Sasithon Pukrittayakamee AU - Aung Pyae Phyo AU - Frank Smithuis AU - Khin Lin AU - Myo Thant AU - Tin Maung Hlaing AU - Parthasarathi Satpathi AU - Sanghamitra Satpathi AU - Prativa K Behera AU - Amar Tripura AU - Subrata Baidya AU - Neena Valecha AU - Anupkumar R Anvikar AU - Akhter ul Islam AU - Abul Faiz AU - Chanon Kunasol AU - Eleanor Drury AU - Mihir Kekre AU - Mozam Ali AU - Katie Love AU - Shavanthi Rajatileka AU - Anna E Jeffreys AU - Kate Rowlands AU - Christina S Hubbart AU - Mehul Dhorda AU - Ranitha Vongpromek AU - Namfon Kotanan AU - Phrutsamon Wongnak AU - Jacob Almagro Garcia AU - Richard D Pearson AU - Cristina V Ariani AU - Thanat Chookajorn AU - Cinzia Malangone AU - T Nguyen AU - Jim Stalker AU - Ben Jeffery AU - Jonathan Keatley AU - Kimberly J Johnson AU - Dawn Muddyman AU - Xin Hui S Chan AU - John Sillitoe AU - Roberto Amato AU - Victoria Simpson AU - Sonia Gonçalves AU - Kirk Rockett AU - Nicholas P Day AU - Arjen M Dondorp AU - Dominic P Kwiatkowski AU - Olivo Miotto TI - Genetic surveillance in the Greater Mekong Subregion and South Asia to support malaria control and elimination AID - 10.1101/2020.07.23.20159624 DP - 2021 Jan 01 TA - medRxiv PG - 2020.07.23.20159624 4099 - http://medrxiv.org/content/early/2021/06/16/2020.07.23.20159624.short 4100 - http://medrxiv.org/content/early/2021/06/16/2020.07.23.20159624.full AB - National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Samples are processed by high-throughput technologies to genotype several drug resistance markers, species markers and a genomic barcode, delivering reports of genotypes and phenotype predictions, used to map prevalence of resistance to multiple drugs. GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9,623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces. GenRe-Mekong facilitates data sharing by aggregating results from different countries, enabling cross-border resistance monitoring.Impact Statement Large-scale genetic surveillance of malaria implemented by National Malaria Control Programmes informs public health decision makers about the spread of strains resistant to antimalarials.Funding Bill & Melinda Gates Foundation, Wellcome Trust, UK Medical Research Council, UK Department for International Development, NIAIDCompeting Interest StatementThe authors have declared no competing interest.Funding StatementBill & Melinda Gates Foundation, Wellcome Trust, UK Medical Research Council, UK Department for International Development, NIAIDAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Oxford Tropical Research Ethics Committee, Oxford, UK; Ethical Committee, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Ministry of Health National Ethics Committee For Health Research, Laos; Ethics Committee, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; National Ethics Committee for Health Research, Ministry of Health, Phnom Penh, Cambodia; Ethics Review Committee on medical research involving human beings from Myanmar, Ministry of Health and Sports, Department of Medical Research (Lower Myanmar); Bangladesh Medical Research Council Ethical Committee; Comite d'Ethique, Ecole de Sante Publique, Universite de Kinshasa, Ministere de l'Enseignement Superieur, Universitaire et Recherche Scientifique, D. R. Congo; Harvard University Human Research Protection Program;All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll genotyping data and metadata is available from the manuscript's resource page. https://www.malariagen.net/resource/29